Synlogic is a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases in need of new treatment options. The Company’s late-stage pipeline is focused on rare metabolic diseases, led by labafenogene marselecobac (SYNB1934), currently being studied as a potential treatment for phenylketonuria (PKU) in Synpheny-3, a global, pivotal Phase 3 study. Additional product candidates address diseases including homocystinuria (HCU), enteric hyperoxaluria, gout, and cystinuria. This pipeline is fueled by the Synthetic Biotic platform, which applies precision genetic engineering to well-characterized probiotics. This enables Synlogic to create GI-restricted, oral medicines designed to consume or modify disease-specific metabolites – an approach well suited for PKU and HCU, both inborn errors of metabolism, as well as other disorders in which the disease–specific metabolites transit through the GI tract, providing validated targets for these Synthetic Biotics. Research activities include a partnership with Roche focused on inflammatory bowel disease (IBD), and a collaboration with Ginkgo Bioworks in synthetic biology, which has contributed to two pipeline programs to date. For more information, please visit www.synlogictx.com
Company Details
- Employees
- 21
- Founded
- -
- Address
- 301 Binney St, Cambridge,massachusetts 02142,united States
- Phone
- (617)401-9975
- in****@****ctx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- synlogictx.com
- Keywords
- Synthetic Biology, Rare Metabolic Diseases, Drug Development, nephrology, rare disease, clinical development, PKU, HCU, IBD, homocystinuria, phenylketonuria, synbio, gout, Synbio, Synthetic Biotics, rare disease, Phase 3.
- HQ
- Cambridge, Massachusetts
Synlogic Questions
Synlogic's helpline number is (617)401-9975
Synlogic's website is synlogictx.com
Synlogic's LinkedIn profile is https://www.linkedin.com/company/synlogic-therapeutics
Synlogic has
21 employees.
View email and phone details for 21
employees at Synlogic.
Synlogic's industry is
Biotechnology Research
Synlogic's top competitors are
Seres Therapeutics,
Cerevance,
Gritstone Bio,
Athersys,
Mei Pharma,
Vbi Vaccines Inc.,
Ginkgo Bioworks, Inc.,
Climb Bio,
Enterome,
Catamaran Bio.
Synlogic's support email address is info@synlogictx.com
Synlogic's categories are Biotechnology Research
Synlogic's founding year is 2014
